Study visit month | S | 0 | 3 | 6 | 9 | 12 |
---|---|---|---|---|---|---|
Study coordination | ||||||
 Obtain informed consent | X |  |  |  |  |  |
 Screen for inclusion/exclusion | X | X |  |  |  |  |
 Randomization |  | X |  |  |  |  |
 Collect updated contact information | X | X | X | X | X | X |
 Reimbursement | X | X | X | X | X | X |
Questionnaires | ||||||
 Demographic information | X | X |  |  |  |  |
 Behavioral questionnaire |  | X |  | X |  | X |
 HIV risk perception |  | X | X | X | X | X |
 Social Harms and Intimate partner violence (IPV) |  | X | X | X | X | X |
 Sexual behavior and exposure history |  | X | X | X | X | X |
 PrEP adherence |  | X | X | X | X | X |
 dPEP adherence (timeline follow-back calendar) |  |  | X a | X a | X a | X a |
 Fertility intention |  | X | X | X | X | X |
 Quality of Life |  | X | X | X | X | X |
Clinical study care | ||||||
 Medication review | X | X | X | X | X | X |
 General symptom assessment |  | X | X | X | X | X |
 WHO pregnancy checklist | X | X | X | X | X | X |
 STI symptom assessment | X | X | X | X | X | X |
 Supply condoms | X | X | X | X | X | X |
 Contraception counseling and provision/referral | X | X | X | X | X | X |
 Risk reduction counseling | X | X | X | X | X | X |
 dPEP pill count and refill |  |  | Xa | X a | X a | X a |
Sample collection | ||||||
 HIV testing (rapid test) | X |  | X | X | X | X |
 Urine pregnancy testing (rapid test) | X b | X | X b | X b | X b | X b |
 Syphilis testing (serum rapid plasma reagin (RPR)) |  | X | X | X | X | X |
 Creatinine (serum) |  | Xb | Xb | Xb | Xb | Xb |
 CT/NG testing and resistance (endocervical swabs) c |  | X | X | X | X | X |
 Hair PrEP and doxycycline drug levels |  | X | X | X | X | X |
 Trichomonas screening (vaginal swab) |  | X | X | X | X | X |